|
US3891427A
(en)
*
|
1972-10-12 |
1975-06-24 |
Lectromelt Corp |
Method for melting prereduced ore and scrap
|
|
SE378735B
(enEXAMPLES)
*
|
1972-11-17 |
1975-09-08 |
Asea Ab |
|
|
US3939297A
(en)
*
|
1973-12-07 |
1976-02-17 |
Chase Brass & Copper Co., Incorporated |
Stoker feed system
|
|
SE7503782L
(sv)
*
|
1975-04-02 |
1976-10-03 |
Asea Ab |
Sett och anordning for smeltreduktion av finkornigt jernoxidhaltigt material
|
|
DE2632707C3
(de)
*
|
1976-07-21 |
1983-04-07 |
Ernst Dipl.-Ing. 4006 Erkrath Beiersdorf |
Beschickungsanlage an Elektro-Lichtbogenöfen zur Zugabe von Legierungsmitteln und Zuschlagstoffen
|
|
US4133967A
(en)
*
|
1977-06-24 |
1979-01-09 |
The United States Of America As Represented By The Secretary Of The Interior |
Two-stage electric arc - electroslag process and apparatus for continuous steelmaking
|
|
US4447906A
(en)
*
|
1981-02-02 |
1984-05-08 |
Lectromelt Corporation |
Arc furnace for producing aluminum
|
|
SE8303372L
(sv)
*
|
1983-06-14 |
1984-12-15 |
Asea Ab |
Ugnsanordning for smeltning av metaller eller metallegeringar
|
|
AT384669B
(de)
*
|
1986-03-17 |
1987-12-28 |
Voest Alpine Ag |
Anlage zur herstellung von stahl aus schrott
|
|
CA1311787C
(en)
*
|
1986-06-24 |
1992-12-22 |
Masahisa Tate |
Method of bottom blowing operation of a steel making electric furnace
|
|
FR2705767B1
(fr)
*
|
1993-05-27 |
1995-07-21 |
Lorraine Laminage |
Procédé et installation de production d'acier liquide à partir de matières ferreuses riches en matières carbonées.
|
|
DE4339226A1
(de)
*
|
1993-11-15 |
1995-05-18 |
Mannesmann Ag |
Verfahren und Vorrichtung zur Wertstoffgewinnung
|
|
LU88517A7
(fr)
*
|
1993-12-15 |
1996-02-01 |
Wurth Paul Sa |
Dispositif de chargement d'un four électrique
|
|
AT404841B
(de)
|
1995-04-10 |
1999-03-25 |
Voest Alpine Ind Anlagen |
Anlage und verfahren zum herstellen von eisenschmelzen
|
|
US6673827B1
(en)
|
1999-06-29 |
2004-01-06 |
The Uab Research Foundation |
Methods of treating fungal infections with inhibitors of NAD synthetase enzyme
|
|
US7227011B2
(en)
|
1998-06-04 |
2007-06-05 |
United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention |
Nucleic acid vaccines for prevention of flavivirus infection
|
|
WO2000070285A1
(en)
*
|
1999-05-18 |
2000-11-23 |
Danieli Technology, Inc. |
Electric arc furnace for continuous charging
|
|
EP1702983A3
(en)
|
2000-04-13 |
2007-01-10 |
Medical University of South Carolina |
Tissue-specific and pathogen-specific toxic agents, ribozymes, DNAzymes and antisense oligonucleotides and methods of use thereof
|
|
CA2415815A1
(en)
*
|
2000-07-06 |
2002-01-17 |
Nigel H. Greig |
Tetrahydrobenzothiazole analogues as neuroprotective agents
|
|
AU2001276957A1
(en)
*
|
2000-07-17 |
2002-01-30 |
Advanced Research And Technology Institute |
Method of diagnosing pulmonary hypertension
|
|
CA2425779C
(en)
|
2000-10-12 |
2013-08-06 |
University Of Rochester |
Compositions that inhibit proliferation of cancer cells
|
|
US20040245317A1
(en)
*
|
2001-04-06 |
2004-12-09 |
Vladimir Larionov |
Artificial chromosomes that can shuttle between bacteria yeast and mammalian cells
|
|
AU2002341938B2
(en)
*
|
2001-10-01 |
2007-08-30 |
Vanderbilt University |
Use of calmodulin kinase II inhibitors to treat myocardial dysfunction in structural heart disease
|
|
AU2002332027A1
(en)
*
|
2001-10-04 |
2003-04-14 |
The Government Of The United States Of America, As |
Tandem repeat markers
|
|
JP2005532263A
(ja)
|
2002-02-06 |
2005-10-27 |
ヴァイコー テクノロジーズ， インコーポレイテッド |
抗梗塞分子
|
|
ES2384439T3
(es)
|
2002-06-14 |
2012-07-04 |
Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Procedimientos de tratamiento y prevención de colitis que se implican IL-13 y células NK-T
|
|
EP1575992A4
(en)
|
2002-08-05 |
2007-02-21 |
Univ Rochester |
CHEMICAL PROTEINS FROM PROTEIN TRANSDUCATING DOMAIN / DEAMINASE, RELATED COMPOUNDS AND THEIR USES
|
|
EP2292259A3
(en)
|
2002-11-15 |
2011-03-23 |
MUSC Foundation For Research Development |
Complement receptor 2 targeted complement modulators
|
|
AU2003294462C1
(en)
|
2002-11-21 |
2011-06-30 |
University Of Utah Research Foundation |
Purinergic modulation of smell
|
|
JP2007518422A
(ja)
|
2004-01-21 |
2007-07-12 |
ユニバーシティ・オブ・ユタ・リサーチ・ファウンデーション |
変異体ナトリウムチャンネルＮａν１．７およびそれに関連する方法
|
|
US8420096B2
(en)
|
2004-03-04 |
2013-04-16 |
Vanderbilt University |
Cell-penetrating SOCS polypeptides that inhibit cytokine-induced signaling
|
|
EP1734821A4
(en)
*
|
2004-04-14 |
2011-07-06 |
Uab Research Foundation |
ACTIVATORS OF HEXOSAMIN BINOSYNTHESIS AS AN INHIBITORS FOR INDUCED DAMAGE CAUSED BY ISCHEMIC SHOCK OR HEMORRHAGIC SHOCK
|
|
US20050244335A1
(en)
*
|
2004-05-03 |
2005-11-03 |
Rinehart John J |
Methods and compositions related to increasing antitumor activity of chemotherapeutic agents
|
|
WO2005110463A1
(en)
|
2004-05-11 |
2005-11-24 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, National Institutes Of Health |
Methods of inhibiting proinflammatory cytokine expression using ghrelin
|
|
CA2564251C
(en)
|
2004-05-21 |
2018-04-10 |
The Uab Research Foundation |
Variable lymphocyte receptors, related polypeptides and nucleic acids, and uses thereof
|
|
US20090118204A1
(en)
*
|
2004-11-18 |
2009-05-07 |
University Of Rochester |
Methods and Compositions Related to Esculentoside A
|
|
RU2438696C2
(ru)
|
2004-12-21 |
2012-01-10 |
Маск Фаундейшн Фор Рисерч Дивелопмент |
Композиции и способы, используемые для ускорения заживления ран и регенерации тканей
|
|
ES2412005T3
(es)
|
2005-04-15 |
2013-07-09 |
The Government Of The United States Of America, As Represented By The Secretary Of Health And Human Services |
Tratamiento y prevención de la enfermedad intestinal inflamatoria que implica IL-13 y células NKT
|
|
US7919104B2
(en)
|
2005-05-19 |
2011-04-05 |
The United States Of America As Represented By The Department Of Health And Human Services, Centers For Disease Control And Prevention |
Functional epitopes of Streptococcus pneumoniae PsaA antigen and uses thereof
|
|
US8859585B2
(en)
*
|
2005-05-25 |
2014-10-14 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Scopolamine for the treatment of depression and anxiety
|
|
PT2468847T
(pt)
|
2005-06-07 |
2017-06-01 |
Dsm Nutritional Products Ag |
Microrganismos eucarióticos para produzir lípidos e antioxidantes
|
|
US8080534B2
(en)
|
2005-10-14 |
2011-12-20 |
Phigenix, Inc |
Targeting PAX2 for the treatment of breast cancer
|
|
US7964577B2
(en)
|
2005-10-14 |
2011-06-21 |
Donald Carlton D |
Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy
|
|
EP2653542B1
(en)
|
2005-12-29 |
2016-06-29 |
The Regents of The University of California |
Methods and compositions related to mutant kunitz domain I of TFPI-2
|
|
TWI515007B
(zh)
*
|
2006-01-05 |
2016-01-01 |
美國猶他大學研究基金會 |
改善以神經系統為標的之藥劑之性質之方法及組合物
|
|
EP2510943B1
(en)
|
2006-02-06 |
2016-04-20 |
The Burnham Institute for Medical Research |
Methods and compositions related to targeting tumors and wounds
|
|
US8470965B2
(en)
*
|
2006-03-01 |
2013-06-25 |
University Of Utah Research Foundation |
Methods and compositions related to cyclic peptide synthesis
|
|
US9365622B2
(en)
*
|
2006-03-01 |
2016-06-14 |
University Of Utah Research Foundation |
Methods and compositions related to cyclic peptide synthesis
|
|
EP1996732A4
(en)
|
2006-03-02 |
2010-03-31 |
Uab Research Foundation |
RECOGNITION AND TREATMENT AND DISCOVERY OF REMEDIES AGAINST MYCOBACTERIAL DISEASES
|
|
AU2007272619B2
(en)
|
2006-07-10 |
2013-07-25 |
Synapsin Pharmaceuticals, Inc. |
Compositions and methods relating to Solenopsins and their uses in treating neurological disorders and enhancing cognitive and physical performance
|
|
DK2049564T3
(en)
|
2006-08-02 |
2017-07-24 |
Uab Res Found |
METHODS AND COMPOSITIONS RELATED TO SOLUBLE MONOCLONAL VARIABLE Lymphocyte RECEPTORS WITH DEFINED ANTIGEN SPECIFICITY
|
|
CA2981308C
(en)
|
2006-09-21 |
2020-12-22 |
University Of Rochester |
Compositions and methods related to protein displacement therapy for myotonic dystrophy
|
|
EP2104516B1
(en)
|
2006-11-01 |
2015-01-07 |
University of Rochester |
Methods and compositions related to the structure and function of apobec3g
|
|
JP2010512327A
(ja)
|
2006-12-11 |
2010-04-22 |
ユニヴァーシティー オブ ユタ リサーチ ファウンデーション |
病的血管形成および脈管透過性の処置用の組成物および方法
|
|
US20120030779A1
(en)
|
2007-01-18 |
2012-02-02 |
University Of Utah Research Foundtion |
Compositions and methods for detecting, treating, or preventing reductive stress
|
|
EP2117576B1
(en)
|
2007-02-08 |
2014-04-16 |
University Of Utah Research Foundation |
Methods and compositions related to inhibition of viral entry
|
|
EP2139319A4
(en)
|
2007-03-22 |
2011-02-23 |
Univ Yale |
METHOD AND COMPOSITIONS FOR RIBOSWITCHES CONTROLLING THE ALTERNATIVE SPLICE
|
|
US8119693B2
(en)
|
2007-05-08 |
2012-02-21 |
Sanford-Burnham Medical Research Institute |
Tissue non-specific alkaline phosphatase inhibitors and uses thereof for treating vascular calcification
|
|
CA2687024A1
(en)
|
2007-05-09 |
2009-02-19 |
Burnham Institute For Medical Research |
Targeting host proteinases as a therapeutic strategy against viral and bacterial pathogens
|
|
US8329195B2
(en)
|
2007-05-23 |
2012-12-11 |
The Uab Research Foundation |
Detoxified pneumococcal neuraminidase and uses thereof
|
|
CA2688575A1
(en)
|
2007-05-29 |
2008-12-24 |
Yale University |
Riboswitches and methods and compositions for use of and with riboswitches
|
|
DK2166845T3
(en)
|
2007-06-21 |
2016-02-01 |
Musc Found For Res Dev |
ALFA-connexin C-terminal (ACT) peptides FOR THE TREATMENT OF AGE-related macular degeneration
|
|
TW200916113A
(en)
|
2007-08-08 |
2009-04-16 |
Sod Conseils Rech Applic |
Method for inhibiting inflammation and pro-inflammatory cytokine/chemokine expression using a ghrelin analogue
|
|
WO2009021163A2
(en)
*
|
2007-08-08 |
2009-02-12 |
University Of Rochester |
Enhancing gene transfer
|
|
EP2190466A4
(en)
*
|
2007-08-10 |
2011-12-21 |
Burnham Inst Medical Research |
Tissue-specific alkaline phosphatase (TNAP) activators and their use
|
|
US8501912B2
(en)
|
2007-12-03 |
2013-08-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Filipil compositions and methods for treating cancer
|
|
US20090233993A1
(en)
*
|
2008-03-06 |
2009-09-17 |
Burnham Institute For Medical Research |
Compositions and methods for inhibiting gsk3 activity and uses thereof
|
|
US20110262395A1
(en)
|
2008-05-08 |
2011-10-27 |
University Of Utah Research Foundation |
Sensory receptors for chronic fatigue and pain and uses thereof
|
|
US20090291073A1
(en)
*
|
2008-05-20 |
2009-11-26 |
Ward Keith W |
Compositions Comprising PKC-theta and Methods for Treating or Controlling Ophthalmic Disorders Using Same
|
|
WO2010027641A2
(en)
*
|
2008-08-15 |
2010-03-11 |
Georgetown University |
Na channels, disease, and related assays and compositions
|
|
EP2370080A1
(en)
|
2008-12-02 |
2011-10-05 |
University of Utah Research Foundation |
Pde1 as a target therapeutic in heart disease
|
|
US20100286762A1
(en)
*
|
2009-03-18 |
2010-11-11 |
Musc Foundation For Research Development |
Compositions and Methods for Ameliorating Clinical Electrical Disturbances
|
|
EP2430161A1
(en)
|
2009-05-15 |
2012-03-21 |
Yale University |
Gemm riboswitches, structure-based compound design with gemm riboswitches, and methods and compositions for use of and with gemm riboswitches
|
|
WO2011020107A2
(en)
|
2009-08-14 |
2011-02-17 |
Georgetown University |
Compositions and methods for detection and treatment of breast cancer
|
|
WO2011022502A1
(en)
|
2009-08-18 |
2011-02-24 |
Georgetown University |
Boronic acid compositions and methods related to cancer
|
|
WO2011031974A1
(en)
|
2009-09-10 |
2011-03-17 |
Southern Research Institute |
Acridine analogs in the treatment of gliomas
|
|
SG182365A1
(en)
|
2010-01-12 |
2012-08-30 |
Univ Yale |
Structured rna motifs and compounds and methods for their use
|
|
US20130045181A1
(en)
|
2010-03-09 |
2013-02-21 |
Guangming Zhong |
Methods and Compositions for Chlamydial Antigens for Diagnosis and Treatment of Chlamydial Infection and Disease
|
|
US20110262347A1
(en)
|
2010-04-08 |
2011-10-27 |
The Salk Institute For Biological Studies |
Methods and compositions for enhanced delivery of compounds
|
|
WO2012021554A1
(en)
|
2010-08-09 |
2012-02-16 |
Yale University |
Cyclic di-gmp-ii riboswitches, motifs, and compounds, and methods for their use
|
|
AU2011343822B2
(en)
|
2010-12-15 |
2017-06-29 |
Neuroadjuvants, Inc. |
Neuropeptide analogs, compositions, and methods for treating pain
|
|
WO2012125869A1
(en)
|
2011-03-15 |
2012-09-20 |
University Of Utah Research Foundation |
Methods of diagnosing and treating vascular associated maculopathy and symptoms thereof
|
|
CA2868735C
(en)
|
2011-03-28 |
2020-02-25 |
University Of Utah Research Foundation |
D-peptide conjugates comprising a membrane localizing potency-enhancing cargo molecule for inhibiting hiv entry
|
|
WO2013036636A1
(en)
|
2011-09-06 |
2013-03-14 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods of treating cancer
|
|
WO2014008475A2
(en)
|
2012-07-05 |
2014-01-09 |
The Ohio State University |
Compositions and methods related to viral vaccines
|
|
WO2014141111A1
(en)
|
2013-03-14 |
2014-09-18 |
Pluristem Ltd. |
Methods for prevention and treatment of graft-versus-host disease
|
|
WO2014201118A2
(en)
|
2013-06-11 |
2014-12-18 |
Sanford-Burnham Medical Research Institute |
Compositions and methods for targeted endometriosis treatment
|
|
PT3016512T
(pt)
|
2013-07-05 |
2020-02-24 |
H Lee Moffitt Cancer Ct & Res |
Cd33 solúvel para tratar síndromes mielodisplásicas (smd)
|
|
US9884895B2
(en)
|
2014-03-20 |
2018-02-06 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for chimeric coronavirus spike proteins
|
|
WO2016049380A1
(en)
|
2014-09-24 |
2016-03-31 |
University Of Utah Research Foundation |
Ebolavirus pre-hairpin intermediate mimics and methods of use
|
|
EP3247807B1
(en)
|
2015-01-20 |
2020-12-16 |
Adcure Biotechnologies, LLC. |
Detargeted adenovirus variants and related methods
|
|
HK1248554A1
(zh)
|
2015-02-20 |
2018-10-19 |
Board Of Regents, The University Of Texas System |
作为疫苗和载体的减毒衣原体的方法和组合物
|
|
WO2017040350A1
(en)
|
2015-08-28 |
2017-03-09 |
Navigen, Inc |
Compositions and methods related to inhibition of respiratory syncytial virus entry
|
|
WO2017120549A1
(en)
|
2016-01-07 |
2017-07-13 |
Navigen, Inc. |
D-peptide inhibitors of hiv entry and methods of use
|
|
MX2018011244A
(es)
|
2016-03-16 |
2019-05-30 |
Abeome Corp |
Anticuerpos monoclonales neutralizantes para il-25 y usos de estos.
|
|
WO2017214197A1
(en)
|
2016-06-06 |
2017-12-14 |
University Of Central Florida Research Foundation, Inc. |
Combination therapy to improve brain function or promote neurogenesis for treating neurodegenerative conditions
|
|
WO2018023114A1
(en)
|
2016-07-29 |
2018-02-01 |
Ohio State Innovation Foundation |
Expression of pten-long with ocolytic viruses
|
|
KR20240042177A
(ko)
|
2016-10-05 |
2024-04-01 |
유니버시티 오브 센트럴 플로리다 리서치 파운데이션, 인코포레이티드 |
Nk 세포 및 항-pdl1 암 요법과 관련된 방법 및 조성물
|
|
WO2018160673A1
(en)
|
2017-02-28 |
2018-09-07 |
University Of Central Florida Research Foundation, Inc. |
Pm21 particles to improve bone marrow homing of nk cells
|
|
EP3600343B1
(en)
|
2017-03-24 |
2022-11-23 |
Ohio State Innovation Foundation |
Novel recombinant adeno-associated viral vectors restricting off-target transduction in liver and uses thereof
|
|
CN110636855B
(zh)
|
2017-03-28 |
2024-08-09 |
俄亥俄州创新基金会 |
人pd1肽疫苗及其用途
|
|
WO2018196782A1
(en)
|
2017-04-27 |
2018-11-01 |
The University Of Hong Kong |
Use of hcn inhibitors for treatment of cancer
|
|
JP7522426B2
(ja)
|
2017-05-25 |
2024-07-25 |
ユニバーシティ オブ セントラル フロリダ リサーチ ファウンデーション，インコーポレイテッド |
天然キラー細胞による殺傷に対する腫瘍細胞の感受性を高めるための新規な腫瘍溶解性ウイルス
|
|
WO2019067403A2
(en)
|
2017-09-26 |
2019-04-04 |
Sanford Burnham Prebys Medical Discovery Institute |
COMPOSITIONS AND METHODS FOR EVALUATION OF PAINFUL DEMYELINIZING AND NON-DEMYELING DISEASES
|
|
EP3723770A4
(en)
|
2017-12-13 |
2021-11-24 |
North Carolina State University |
COMPOSITIONS INCLUDING CHEMOTHERAPEUTIC AGENTS AND CHECKPOINT INHIBITORS AND METHODS OF USE
|
|
EP3773742A4
(en)
|
2018-04-06 |
2022-03-16 |
North Carolina State University |
CELL SET-MEDIATED CHECKPOINT INHIBITOR DELIVERY FOR CANCER IMMUNOTHERAPY
|
|
EP3787655A4
(en)
|
2018-05-07 |
2022-08-10 |
Georgia State University Research Foundation Inc. |
Compositions and methods related to rhamnus prinoides (gesho) extract for the inhibition of polymicrobial biofilm formation
|
|
AU2019271366A1
(en)
|
2018-05-16 |
2021-01-14 |
Research Institute At Nationwide Children's Hospital |
Generation of knock-out primary and expanded human NK cells using Cas9 ribonucleoproteins
|
|
EP3813884B1
(en)
|
2018-06-29 |
2024-09-18 |
North Carolina State University |
In situ sprayed bioresponsive immunotherapeutic gel for post-surgical treatment
|
|
US11331269B2
(en)
|
2018-09-06 |
2022-05-17 |
Massachusetts Institute Of Technology |
Methods and compositions targeting lung microbiota and its responding immune pathways for lung cancer treatment
|
|
EP3847650A1
(en)
|
2018-09-06 |
2021-07-14 |
The Broad Institute, Inc. |
Nucleic acid assemblies for use in targeted delivery
|
|
EP4588483A3
(en)
|
2018-10-03 |
2025-09-24 |
University of Pittsburgh- Of the Commonwealth System of Higher Education |
Covalent adaptor synnotch and chimeric antigen receptors (cars) for programmable antigen-targeting
|
|
WO2020092057A1
(en)
|
2018-10-30 |
2020-05-07 |
Yale University |
Compositions and methods for rapid and modular generation of chimeric antigen receptor t cells
|
|
EP3873505A4
(en)
|
2018-11-02 |
2022-08-10 |
The Johns Hopkins University |
ADENOVIRAL CHIMERIC TDP-43 PROTEINS
|
|
US20220136064A1
(en)
|
2019-02-09 |
2022-05-05 |
King Abdullah University Of Science And Technology |
Compositions and methods for cancer diagnosis and prognosis
|
|
WO2020257640A1
(en)
|
2019-06-21 |
2020-12-24 |
Vaccinex, Inc. |
Combination therapy with semaphorin-4d blockade (sema4d) and dc1 therapy
|
|
WO2021011935A1
(en)
|
2019-07-18 |
2021-01-21 |
Direct Biologics, Llc |
Preparations comprising mesenchymal stem cells and cannabinoids and methods of their use
|
|
KR20230002571A
(ko)
|
2020-04-14 |
2023-01-05 |
더 리전츠 오브 더 유니버시티 오브 캘리포니아 |
큰 서열 범-코로나바이러스 백신 조성물
|
|
US11225508B1
(en)
|
2020-09-23 |
2022-01-18 |
The University Of North Carolina At Chapel Hill |
Mouse-adapted SARS-CoV-2 viruses and methods of use thereof
|
|
EP4251283A1
(en)
|
2020-11-27 |
2023-10-04 |
General Nanotherapeutics LLC |
Methods and composition for treatment of immune-mediated diseases
|
|
US20230279442A1
(en)
|
2021-12-15 |
2023-09-07 |
Versitech Limited |
Engineered cas9-nucleases and method of use thereof
|
|
KR102436232B1
(ko)
*
|
2022-01-17 |
2022-08-25 |
주식회사 세명하이트 |
원통형 필터 제조방법 및 이에 따라 제조된 원통형 필터
|
|
US20250228940A1
(en)
|
2022-03-11 |
2025-07-17 |
Yale University |
Compositions and methods for efficient and stable genetic modification of eukaryotic cells
|
|
WO2023220644A1
(en)
|
2022-05-10 |
2023-11-16 |
Yale University |
Compositions and methods of synthetic ctla-4 tails for reprogramming of car-t cells and enhancement of anti-tumor efficacy
|
|
KR102751454B1
(ko)
*
|
2022-06-03 |
2025-01-10 |
현대제철 주식회사 |
전기로
|
|
KR102736561B1
(ko)
*
|
2022-06-03 |
2024-12-02 |
현대제철 주식회사 |
전기로
|
|
KR102829902B1
(ko)
*
|
2022-07-29 |
2025-07-04 |
현대제철 주식회사 |
전기로
|
|
KR102777625B1
(ko)
*
|
2022-07-29 |
2025-03-11 |
현대제철 주식회사 |
전기로
|
|
KR102752443B1
(ko)
*
|
2022-08-26 |
2025-01-09 |
현대제철 주식회사 |
전기로
|
|
KR102793154B1
(ko)
*
|
2022-08-26 |
2025-04-07 |
현대제철 주식회사 |
전기로
|
|
WO2024064824A2
(en)
|
2022-09-21 |
2024-03-28 |
Yale University |
Compositions and methods for identification of membrane targets for enhancement of nk cell therapy
|
|
WO2024102997A1
(en)
|
2022-11-11 |
2024-05-16 |
Peterson Jeff R |
Gout flare prevention methods using il-1β inhibitors
|
|
KR102799788B1
(ko)
*
|
2022-11-29 |
2025-04-22 |
현대제철 주식회사 |
전기로용 저취교반장치 및 이를 포함하는 전기로
|
|
WO2024155821A1
(en)
|
2023-01-18 |
2024-07-25 |
Yale University |
Chimeric antigen receptors (car) with intrinsically disordered regions and methods of use thereof
|
|
WO2024226829A2
(en)
|
2023-04-26 |
2024-10-31 |
Yale University |
Enpp3-binding molecules, compositions formed therefrom, and methods of use thereof for the treatment of cancer
|
|
WO2024238656A1
(en)
|
2023-05-15 |
2024-11-21 |
Yale Univeristy |
Chimeric antigen receptor compositions, car-mast cells formed therefrom, and methods of use thereof
|
|
US12269875B2
(en)
|
2023-08-03 |
2025-04-08 |
Jeff R. Peterson |
Gout flare prevention methods using IL-1BETA blockers
|
|
WO2025158400A1
(en)
|
2024-01-24 |
2025-07-31 |
Yale University |
Compositions and methods of natural killer cell hyperboosts for enhancement of nk cell therapy
|